Sleep Apnea Implant Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Global Sleep Apnea Implant Market is segmented by Product Type (Hypoglossal Neurostimulation Devices, Phrenic Nerve Stimulator, and Palatal Implants), Indication Type (Obstructive Sleep Apnea, Central Sleep Apnea), End User (Hospitals, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Sleep Apnea Implant Market Size

Compare market size and growth of Sleep Apnea Implant Market with other markets in Healthcare Industry

Sleep Apnea Implant Market Analysis

The Sleep Apnea Implant Market is expected to register a CAGR of 10.5% during the forecast period.

COVID-19 had a substantial impact on the sleep apnea implant market since patients with sleep apnea experienced worsening symptoms after affecting COVID-19. The infection promoted airway irritation, making sleep breathing more difficult. Such an important life event is likely to interrupt sleep and have an impact on market growth. For instance, as per the article published in February 2022 in ERJ journal, the researchers showed a significant correlation between increased prevalence and severity of sleep apnea during recovery from illness and the severity of SARS-CoV-2 infection. However, as the restrictions are lifted, and COVID-19 cases are reduced, the market is anticipated to witness growth in the coming years due to the increase in demand for sleep apnea implants, rapid technological advancements, and a rise in sleep disorders.

The growth of the sleep apnea implant market can be attributed to factors such as the rise in sleep disorders and technological advancements in sleep apnea implants. For instance, as per the Advisor 2023 update, about 70 million people in the United States suffer from sleep disorders. In addition, research studies demonstrating the technological advancements of sleep apnea implants are anticipated to boost market growth over the forecast period. For instance, as per the article published in February 2022 in PubMed, mini-implant assisted rapid palatal expansion (MARPE), which increased the size of the nasal and oral cavities and widens the midface, which helped in some patients with OSA therapy by reducing airflow resistance. Furthermore, in February 2022, LivaNova PLC marked its first investigational device exemption study, as the patient was implanted with the company's obstructive sleep apnea (OSA) treatment device. The company's randomized controlled study, 'Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation' (OSPREY), seeks to demonstrate the safety and effectiveness of the LivaNova aura6000 System, an implantable hypoglossal neurostimulator intended to treat adult patients with moderate to severe OSA.

Thus, due to the rise in sleep apnea cases and the surge in technological advancements in sleep apnea implants, the studied market is anticipated to witness growth over the forecast period. However, the high cost of sleep apnea implants is likely to restrain the market growth over the forecast period.

Sleep Apnea Implant Industry Overview

The market is consolidated and consists of major players. The increasing focus of market players for the development of innovative products are driving the growth of the market. Some of the companies which are currently dominating the market are Medtronic, Respicardia Inc., Inspire Medical Systems, Siesta Medical Inc., LivaNova PLC, and LinguaFlex.

Sleep Apnea Implant Market Leaders

  1. Medtronic

  2. Inspire Medical Systems

  3. LivaNova PLC

  4. ZOLL Medical Corporation

  5. Nyxoah SA

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF

Sleep Apnea Implant Market News

  • January 2023: NHS doctors have begun treating people with sleeping disorders using a pioneering implant that helps patients get a better night's rest. The procedure involves implanting a small device in the chest of people with sleep apnoea to prevent their breathing from stopping and starting hundreds of times while they are asleep. Guy's and St Thomas' (GSTT) health trust in London has become the first NHS care provider to use the device.
  • August 2022: StimAire Australia Pty Ltd sponsored a clinical study to evaluate the change in Apnea-Hypopnea Index (AHI) when using the StimAire Model S system. The StimAire Model S is intended to treat Obstructive Sleep Apnea (OSA) by stimulating the hypoglossal nerve. The system includes a dedicated neurostimulator and a breathing sensor. The system will be used in participants diagnosed with moderate to severe Obstructive Sleep Apnea.

Sleep Apnea Implant Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements in Sleep Apnea Devices
    • 4.2.2 Rise in Burden of Sleep Disorders
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Sleep Apnea Implants
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Hypoglossal Neurostimulation Devices
    • 5.1.2 Phrenic Nerve Stimulator
    • 5.1.3 Palatal Implants
  • 5.2 By Indication Type
    • 5.2.1 Obstructive Sleep Apnea
    • 5.2.2 Central Sleep Apnea
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Office Based Clinics
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Inspire Medical Systems
    • 6.1.2 LinguaFlex
    • 6.1.3 LivaNova PLC
    • 6.1.4 Medtronic
    • 6.1.5 ZOLL Medical Corporation
    • 6.1.6 Siesta Medical Inc.
    • 6.1.7 Nyxoah SA
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Sleep Apnea Implant Industry Segmentation

As per the scope of the report, a sleep apnea implant is an implantable device that stimulates the muscles of the tongue and upper airway during sleep. These implantable devices improve airflow. It's also called a hypoglossal nerve stimulator or upper airway stimulation device. The device is implanted in the upper right chest beneath the skin. The Sleep Apnea Implant Market is Segmented by Product Type (Hypoglossal Neurostimulation Devices, Phrenic Nerve Stimulator, and Palatal Implants), Indication Type (Obstructive Sleep Apnea, Central Sleep Apnea), End User (Hospitals, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type Hypoglossal Neurostimulation Devices
Phrenic Nerve Stimulator
Palatal Implants
By Indication Type Obstructive Sleep Apnea
Central Sleep Apnea
By End User Hospitals
Ambulatory Surgical Centers
Office Based Clinics
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Sleep Apnea Implant Market Research FAQs

What is the current Sleep Apnea Implant Market size?

The Sleep Apnea Implant Market is projected to register a CAGR of 10.5% during the forecast period (2025-2030)

Who are the key players in Sleep Apnea Implant Market?

Medtronic, Inspire Medical Systems, LivaNova PLC, ZOLL Medical Corporation and Nyxoah SA are the major companies operating in the Sleep Apnea Implant Market.

Which is the fastest growing region in Sleep Apnea Implant Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Sleep Apnea Implant Market?

In 2025, the North America accounts for the largest market share in Sleep Apnea Implant Market.

What years does this Sleep Apnea Implant Market cover?

The report covers the Sleep Apnea Implant Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Sleep Apnea Implant Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Hot and Cold Therapy Disposable Icepacks Industry Report

Statistics for the 2025 Sleep Apnea Implant market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Sleep Apnea Implant analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Sleep Apnea Implant Market Report Snapshots

Sleep Apnea Implant Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)